Valerie Treyer

Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background Women are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown. Aim We assessed the impact of sex and gender on PASC in a Swiss population. Method Our multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection. Results Among those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41–1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03–1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74–1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01–1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03–1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29–2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60–0.97; p = 0.030). Conclusion Specific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Henrik Zetterberg

Professor

University of Gothenburg

SWEDEN
View details

Catherine Gebhard

University of Zurich

SWITZERLAND
View details

Kris Thielemans

Professor in Medical Imaging Physics

University College London

UNITED KINGDOM
View details

Ahmed Haider

Emory University School of Medicine

UNITED STATES
View details

Sandro Thomas Studer

University of Zurich

SWITZERLAND
View details

Antonio Giulio Gennari

University Children's Hospital Zurich

SWITZERLAND
View details

Susanne Wegener

University Hospital of Zurich

SWITZERLAND
View details

Matthias Preusser

Medical University

AUSTRIA
View details

Caroline E. Gebhard

University Hospital Basel

SWITZERLAND
View details

Silvio Daniel Brugger

University of Zurich

SWITZERLAND
View details

Adrian Preda

University of California Irvine School of Medicine

UNITED STATES
View details

Vera Regitz-Zagrosek

Director, Prof. dr. Dr.

Charité - Universitätsmedizin Berlin

GERMANY
View details

Martina Sebök

University Hospital of Zurich

SWITZERLAND
View details

Philipp Antonio Kaufmann

Professor of Nuclear Medicine

University of Zurich

SWITZERLAND
View details

Ronny Ralf Buechel

University Hospital of Zurich

SWITZERLAND
View details

Ruiqing Ni

University of Zurich

SWITZERLAND
View details

Christian Kellenberger

University of Zurich

SWITZERLAND
View details

Joerg C. Schefold

University Hospital of Bern

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.